, Keywords: C-H activation ? Isotopic labelling ? Nanoparticles ? Hydrogen isotope exchange ? Oligonucleotides
, Nucleosides and Nucleotides as Antitumor and Antiviral Agents, 1993.
, Ann. Rev. Pharmacol. Toxicol, vol.50, pp.259-293, 2010.
, Nature, vol.391, pp.806-811, 1998.
, Nat. Rev. Genet, vol.16, pp.543-552, 2015.
, Nat. Rev. Genet, vol.9, pp.329-340, 2003.
, Angew. Chem. Int. Ed, vol.57, pp.3022-3047, 2018.
, J. Label. Compd. Radiopharm, vol.55, pp.235-257, 2012.
, Angew. Chem. Int. Ed, vol.57, pp.1758-1784, 2018.
, J. Label. Compd. Radiopharm, vol.27, pp.683-690, 1989.
, J. Label. Compd. Radiopharm, vol.12, pp.487-491, 1980.
, Biochemistry, vol.6, pp.2735-2739, 1967.
, Synlett, pp.1385-1388, 2005.
, Angew. Chem. Int. Ed, vol.53, pp.2986-2989, 2014.
, Bioorg. Med. Chem. Lett, vol.12, pp.9669-9670, 1990.
33-41; b) Regarding caffeine 10, when using 5 mol% of the catalyst, only the incorporation of deuterium atoms resulting from the preferential coordination site N-9 is observed at positions 8 and 3 (N-CH3), vol.50, 2007. ,
, J. Label. Compd. Radiopharm, vol.284, pp.683-690, 1977.
, Acc. Chem. Res, vol.53, pp.376-384, 2017.
, One example of tritiation of nucleobase derivative (Famciclovir, vol.1
, Ci/mmol) was described using Ni catalyzed HIE, vol.8, pp.10210-10218, 2018.
, Biotechnology J, vol.6, pp.1130-1146, 2011.
, Curr. Med. Chem, vol.13, pp.48-59, 2003.
, J. Clin. Oncol, vol.23, pp.3404-3411, 2005.
, J. Pharm. Biomed. Anal, vol.44, pp.330-341, 2007.
, J. Chromatogr. B, vol.6, pp.1386-1389, 2008.
, Bioanalysis, vol.4, pp.1457-1469, 2012.
, J. Pharm. Biomed. Anal, vol.6, pp.300-307, 2014.
, BMC Res. Notes, vol.11, pp.708-711, 2018.